Celgene will grant Sun Pharma a license to Celgenes patents required to manufacture and sell a certain limited quantity of generic lenalidomide capsules in the US beginning on a confidential date that is sometime after March 2022.

from India Infoline News Service https://ift.tt/3wQUq7w